Access and appointments
How the UK private medical cannabis prescription pathway works
Private care usually involves an eligibility review, a specialist assessment, a prescribing decision, dispensing by a pharmacy and ongoing clinical follow-up. Paying for an appointment does not guarantee a prescription.
The pathway at a glance
- Check the provider, likely costs and information requirements.
- Supply relevant medical records and identification securely.
- Attend a clinical assessment with an appropriate specialist service.
- Receive an individual prescribing decision—not a guaranteed approval.
- If prescribed, pay the private pharmacy and wait for lawful dispensing and delivery or collection.
- Attend follow-up reviews and report benefits, problems and side effects honestly.
Before booking
Confirm who regulates the provider, which doctors prescribe, which pharmacy may dispense, and the full likely cost—not only the first consultation fee. In England, independent services carrying on regulated treatment activities generally need Care Quality Commission registration. Other UK nations have their own healthcare regulators.
- Ask which records the clinic needs and how they will be transferred securely.
- Check consultation, repeat-prescription, pharmacy and delivery charges.
- Read cancellation, refund, complaints and safeguarding policies.
- Be cautious of guaranteed eligibility, guaranteed products or pressure to pay quickly.
Clinical assessment
The clinician should assess your condition, treatment history, current medicines, relevant physical and mental-health history, risks, goals and alternatives. NHS England states that private doctors on the GMC Specialist Register can legally prescribe cannabis-based products for medicinal use, and expects non-NHS prescribing to follow equivalent safeguards for unlicensed special medicines.
Prescribing decision and consent
Many cannabis-based medicinal products are controlled drugs and unlicensed medicines. CQC guidance says unlicensed products can only be prescribed by, or under the direction of, a doctor on the GMC Specialist Register working within their competence. The clinician should explain expected benefits, material risks, uncertainties, alternatives and monitoring before you agree to treatment.
Prescription and pharmacy
If prescribed, the prescription is sent to an appropriate pharmacy for clinical and legal checks. The medicine is not supplied merely because a consultation was completed. Availability, prescription corrections, payment and controlled-drug requirements can affect timing.
- Check the exact product, formulation, strength, quantity and directions.
- Ask who to contact if the item is unavailable or the label is unclear.
- Keep the medicine in its original packaging with the dispensing label.
- Do not use an alternative product or change the directions without professional advice.
Follow-up and ongoing care
Follow-up is part of treatment, not an optional administrative extra. The service may review symptoms, adverse effects, adherence, other medicines, product suitability and whether treatment should continue or change. Report concerns promptly and use the MHRA Yellow Card scheme where appropriate.
Your GP does not automatically take over private prescribing. Any shared-care arrangement must be agreed by the clinicians involved; a private recommendation does not oblige an NHS GP to prescribe.
Costs to clarify in writing
- Initial eligibility or records-review fee.
- First specialist consultation.
- Follow-up consultation frequency and cost.
- Repeat-prescription or administration fees.
- Medicine and pharmacy charges.
- Delivery, replacement or cancellation charges.
Ask for the likely recurring monthly cost and what happens if the clinician decides not to prescribe.
Once a prescription is issued
Make the wording easier to check.
Use the Prescription Translator to confirm the product, quantity and directions in plain English. It does not replace the dispensing label or advice from the clinic or pharmacy.